- Home
- IGMS vs ESP Comparison
IGMS vs ESP Comparison
Compare IGMS & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGMS
- ESP
- Stock Information
- Founded
- IGMS 1993
- ESP 1928
- Country
- IGMS United States
- ESP United States
- Employees
- IGMS N/A
- ESP N/A
- Industry
- IGMS Biotechnology: Pharmaceutical Preparations
- ESP Industrial Machinery/Components
- Sector
- IGMS Health Care
- ESP Technology
- Exchange
- IGMS Nasdaq
- ESP Nasdaq
- Market Cap
- IGMS 82.1M
- ESP 84.1M
- IPO Year
- IGMS 2019
- ESP N/A
- Fundamental
- Price
- IGMS $1.22
- ESP $29.12
- Analyst Decision
- IGMS Hold
- ESP
- Analyst Count
- IGMS 8
- ESP 0
- Target Price
- IGMS $6.14
- ESP N/A
- AVG Volume (30 Days)
- IGMS 167.6K
- ESP 16.1K
- Earning Date
- IGMS 05-07-2025
- ESP 05-12-2025
- Dividend Yield
- IGMS N/A
- ESP 3.40%
- EPS Growth
- IGMS N/A
- ESP 31.14
- EPS
- IGMS N/A
- ESP 2.45
- Revenue
- IGMS $2,679,000.00
- ESP $43,917,522.00
- Revenue This Year
- IGMS $121.76
- ESP N/A
- Revenue Next Year
- IGMS $46.83
- ESP N/A
- P/E Ratio
- IGMS N/A
- ESP $11.87
- Revenue Growth
- IGMS 25.77
- ESP 18.62
- 52 Week Low
- IGMS $0.92
- ESP $20.20
- 52 Week High
- IGMS $22.50
- ESP $33.00
- Technical
- Relative Strength Index (RSI)
- IGMS 47.65
- ESP 60.16
- Support Level
- IGMS $1.16
- ESP $24.85
- Resistance Level
- IGMS $1.31
- ESP $29.44
- Average True Range (ATR)
- IGMS 0.12
- ESP 1.28
- MACD
- IGMS 0.03
- ESP 0.39
- Stochastic Oscillator
- IGMS 76.92
- ESP 76.11
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.